Literature DB >> 27252851

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

Hang Zhang1, Juan Zhang1, Du-Jiang Xie2, Xiaoming Jiang2, Feng-Fu Zhang2, Shao-Liang Chen2.   

Abstract

Pulmonary hypertension (PH) predicts poor outcome in patients with left heart disease. A 62-year-old man was referred for heart failure associated with ischemic cardiomyopathy. He received a diagnosis of combined postcapillary and precapillary PH secondary to left heart disease on the basis of hemodynamic parameters. After the pulmonary artery denervation procedure was performed, hemodynamic parameters were markedly improved, which resulted in a significant increase in functional capacity.

Entities:  

Keywords:  heart failure; pulmonary artery denervation; pulmonary hypertension

Year:  2016        PMID： 27252851      PMCID： PMC4869929          DOI： 10.1086/685550

Source DB:  PubMed          Journal:  Pulm Circ        ISSN： 2045-8932            Impact factor:   3.017


  13 in total

Review 1.  Pulmonary hypertension in advanced heart failure.

Authors:  Stefano Ghio
Journal:  Herz       Date:  2005-06       Impact factor: 1.443

Review 2.  Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.

Authors:  Francois Haddad; Kristina Kudelko; Olaf Mercier; Bojan Vrtovec; Roham T Zamanian; Vinicio de Jesus Perez
Journal:  Prog Cardiovasc Dis       Date:  2011 Sep-Oct       Impact factor: 8.194

Review 3.  Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives.

Authors:  Marco Guazzi
Journal:  Circ Heart Fail       Date:  2014-03-01       Impact factor: 8.790

4.  Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature.

Authors:  C E Juratsch; J A Jengo; J Castagna; M M Laks
Journal:  Chest       Date:  1980-04       Impact factor: 9.410

5.  Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).

Authors:  Shao-Liang Chen; Feng-Fu Zhang; Jing Xu; Du-Jiang Xie; Ling Zhou; Thach Nguyen; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

6.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

7.  Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.

Authors:  Xiaojing Wu; Te Yang; Qi Zhou; Shuangfei Li; Lan Huang
Journal:  Eur J Heart Fail       Date:  2013-12-31       Impact factor: 15.534

8.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.

Authors:  Shao-Liang Chen; Yao-Jun Zhang; Lin Zhou; Du-Jiang Xie; Feng-Fu Zhang; Hai-Bo Jia; Sally S Wong; Tak W Kwan
Journal:  EuroIntervention       Date:  2013-06-22       Impact factor: 6.534

10.  Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.

Authors:  Alexander M K Rothman; Nadine D Arnold; William Chang; Oliver Watson; Andrew J Swift; Robin Condliffe; Charlie A Elliot; David G Kiely; S Kim Suvarna; Julian Gunn; Allan Lawrie
Journal:  Circ Cardiovasc Interv       Date:  2015-11       Impact factor: 6.546
View more
  6 in total

Review 1.  The progress of pulmonary artery denervation.

Authors:  Yonghui Xie; Na Liu; Zhenghui Xiao; Fang Yang; Yunhong Zeng; Zhou Yang; Yuanxi Xia; Zhi Chen; Yunbin Xiao
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 3.487

2.  Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling.

Authors:  Yongpeng Zhao; Rui Xiang; Xin Peng; Qian Dong; Dan Li; Guiquan Yu; Lei Xiao; Shu Qin; Wei Huang
Journal:  Respir Res       Date:  2019-06-14

3.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

Review 4.  Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension.

Authors:  Wanyun Zuo; Na Liu; Yunbin Xiao; Yonghui Xie; Qiming Liu
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16

Review 5.  Current status of pulmonary artery denervation.

Authors:  Mark G Davies; Dimitrios Miserlis; Joseph P Hart
Journal:  Front Cardiovasc Med       Date:  2022-10-03

6.  Electrical Stimulation-Guided Approach to Pulmonary Artery Catheter Ablation in Patients with Idiopathic Pulmonary Arterial Hypertension: A Pilot Feasibility Study with a 12-Month Follow-Up.

Authors:  Natalia S Goncharova; Olga M Moiseeva; Heber Ivan Condori Leandro; Irina S Zlobina; Aelita V Berezina; Kirill N Malikov; Dmitry M Tashkhanov; Dmitry S Lebedev; Evgeny N Mikhaylov
Journal:  Biomed Res Int       Date:  2020-02-17       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.